Meeting Agenda
PCOS EL-PFDD Meeting
9:15 - 10:00 AM
Check-In / On-Site Registration
Pick up name badge and meeting materials. Coffee, tea and fruit available at check-in.
10:00 - 10:05 AM
Welcome and Opening Remarks
- Sasha Ottey, MHA, MT (ASCP)Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association
10:05 - 10:20 AM
Patient-Centered Therapies: The Role of the Patient in Drug Development/Overview of FDA’s Patient-Focused Drug Development Initiative
- Audrey Gassman, MDDeputy Director Division of Urology Obstetrics and Gynecologic Products Office of New Drugs/Center for Drug Evaluation FDA
10:20 - 10:35 AM
Overview of PCOS and Current Treatment Options
- Anuja Dokras, MD, PhDDirector, PENN Polycystic Ovary Syndrome Center
PCOS Challenge Scientific Advisory Board
10:35 - 10:40 AM
10:40 - 11:00 AM
Panel Discussion on Topic 1: Living with PCOS – Health Effects and Daily Impacts
Topic 1: A panel of PCOS patients will provide comments to start the discussion on the health effects and daily impacts of PCOS.- Martha McKittrick, RDN, CDE
Moderator
11:00 - 12:15 PM
Large-Group Facilitated Discussion: Topic 1
Patients and patient representatives in the audience will be invited to add to the dialogue.- Martha McKittrick, RDN, CDE
Moderator
12:15 - 12:45 PM
Lunch Break
Lunch Provided
12:45 - 1:05 PM
Panel Discussion on Topic 2: Patients’ Perspectives on Current Approaches and Challenges to Treatment
Topic 2: A panel of PCOS patients will provide comments to start the discussion on current approaches and challenges to treating PCOS and PCOS symptoms.- Martha McKittrick, RDN, CDE
Moderator
1:05 - 2:20 PM
Large-Group Facilitated Discussion: Topic 2
Patients and patient representatives in the audience will be invited to add to the dialogue.- Martha McKittrick, RDN, CDE
Moderator
2:20 - 2:30 PM
Closing Remarks
- Sasha Ottey, MHA, MT (ASCP)Founder and Executive Director of PCOS Challenge
Open Public Comment, Meeting Summary and Next Steps
PCOS PFDD MEETING - Register Now
Join us as we help shape and accelerate the future of treatment for polycystic ovary syndrome (PCOS).